A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection Against HSV-1 and HSV-2 Genital Infections

Journal of Virology - United States
doi 10.1128/jvi.00302-12

Related search